Press Announcements > FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients

Press Announcements > FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients

FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients

Today, the U.S. Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients. Continue reading.